参考文章:
[1] http://www.chc.org.cn/news/detail.php?id=55544
[2] https://www.who.int/health-topics/obesity#tab=tab_2
[3] A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway. J. Agric. Food Chem. 2014; 62:8952–8961.
[4]Lo HY, Ho TY, Lin C, Li CC, Hsiang CY. Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor. J Agric Food Chem. 2013; 61:2461-2468
[5] Lo H.Y., Li C.C., Ho T.Y., Hsiang C.Y. Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein. Food Chem. 2016; 204:298–305.
[6] Hsu PK, Pan FFC, Hsieh CS. mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients’ Blood Sugar Levels. Nutrients. 2020; 12:1252.
[7] Pan F, Hsu PK, Chang WH. Exploring the Factors Affecting Bitter Melon Peptide Intake Behavior: A Health Belief Model Perspective. Risk Manag Healthc Policy. 2020; 13:2219-2226.
[8] https://insumate.org/body_shape/?lang=zh-hans